Comprehensive HBV Antigen Detection

Hepatitis B Virus (HBV) Multi Combo Antigen Rapid Test

Simultaneous detection of HBsAg, HBeAg, and HBcAg in serum or plasma for HBV infection monitoring.

CE Certified
ISO 13485
Main image of Hepatitis B Virus (HBV) Multi Combo Antigen Rapid Test

Why Choose reOpenTest Infectious Disease Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Rapid Detection

Fast results in 15-20 minutes.

Multiple Antigens

Simultaneously detects HBsAg, HBeAg, and HBcAg.

Infection Monitoring

Aids in the early detection and monitoring of HBV infection.

Product Overview

The HBV Multi Combo Antigen Rapid Test is a qualitative in-vitro diagnostic device designed for the simultaneous detection of Hepatitis B surface antigen (HBsAg), Hepatitis B e antigen (HBeAg), and Hepatitis B core antigen (HBcAg) in human serum or plasma. This rapid test provides a valuable tool for the early detection and monitoring of Hepatitis B infection.

Technical Specifications

Detection Target HBsAg, HBeAg, HBcAg
Sample Type Serum, Plasma
Methodology Immunochromatography
Detection Range Qualitative (Positive/Negative)
Reaction Time 15-20 minutes
Storage Conditions 2-30u00b0C
Shelf Life 24 months

Procedure & Interpretation

Step-by-Step Procedure

  1. Collect serum or plasma sample.
  2. Apply sample to the test device.
  3. Wait 15-20 minutes.
  4. Read and interpret the results.

Result Interpretation

Positive Result
Positive: The presence of lines for HBsAg, HBeAg, and/or HBcAg indicates a positive result for the respective antigen(s).
Negative Result
Negative: The absence of lines for HBsAg, HBeAg, and HBcAg indicates a negative result.
Invalid Result
Invalid: If no lines appear or the control line is absent, the test is invalid and should be repeated.

Frequently Asked Questions

Simultaneous detection provides a comprehensive assessment of HBV infection status, aiding in early diagnosis, monitoring disease progression, and determining treatment strategies.

HBeAg detection indicates active viral replication and high infectivity, helping to identify patients who are more likely to transmit the virus.

While the test can detect the presence of HBV antigens, quantitative assays are typically used to monitor viral load and assess the response to antiviral therapy.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Partner with reOpenTest

Provide your clients and patients with reliable diagnostic solutions.
Contact us today for bulk pricing and distribution opportunities.

Become a Distributor